During these trying times, we remain open, and are ready and able to sign up new clients while fighting for the rights of our current clients. In order to help protect the health of our potential clients, current clients, and staff, we are actively utilizing video teleconferencing and e-sign digital signatures, in addition to phone and email. No matter the distance between us, our priority remains the same – to fight for the best interests of our clients. Please do not hesitate to reach out to us during this time. Don’t let COVID-19 prevent you from getting the justice you deserve.

Zofran Linked to Birth Defects

FREE CASE EVALUATION

The U.S. Food and Drug Administration have issued a warning against Zofran (Ondansetran) use for treating morning sickness in pregnant women. Zofran was approved by the FDA to prevent nausea related to chemotherapy treatments in cancer patients. However, Zofran has been prescribed off label to pregnant women to help treat morning sickness.

Zofran was not tested for use in pregnancy and preliminary studies reveal a link to Zofran and birth defects. Lawsuits claim that GlaxoSmithKline, Zofran’s drugmaker, knew there were dangers associated with Zofran for developing babies, yet continued to market its use to treat morning sickness.

According to lawsuits, birth defects linked to Zofran use are:

  • Heart defects
  • Cleft lips
  • Club feet
  • Craniosynostosis
  • Cleft palates

If you or a loved one sustained injuries due to a defective drug, unsafe drug lawyers may be able to help you obtain the justice you deserve. For more information, call 1-888-BURNETTI.

Share on facebook
Share on twitter
Share on reddit
Share on linkedin
burnetti logo white
Let's get started with your FREE consultation
burnetti logo white
Empecemos con su consulta gratis